<h1>Trade agreements expand market access for Indian pharma, enhancing exports to highly regulated markets and regulatory approvals.</h1> Pharmaceutical exports have grown markedly since 2013-14 and sustained positive growth despite global disruptions, yielding a favourable trade balance. Formulations and biologicals dominate exports, with around half directed to highly regulated markets and a large number of FDA approved plants located in India. Government pursuit of trade agreements and cooperation pacts aims to enhance market access and integrate Indian firms into global regulated supply chains.